Med. Pro Praxi 2008; 5(1): 41-44

Farmakologická léčba bolestí hlavy

MUDr. Ingrid Niedermayerová
Neurologická ambulance, Quattromedica, Brno a externě Neurologická klinika FN Brno

V terapii migrény se v současnosti uplatňuje tzv. stratifikovaná léčba. U lehkých záchvatů podáváme analgetika a antirevmatika perorálně, u středně těžkých aplikujeme tyto léky parenterálně, přidáváme antiemetika. Specifická antimigrenika, tzv. triptany jsou indikována u středně těžkých a těžkých záchvatů. Při nárůstu frekvence či nedostatečném efektu akutní léčby nasazujeme profylaxi ze skupiny betablokátorů, antiepileptik či antidepresiva. Tenzní bolest hlavy léčíme jednoduchými analgetiky, v případě nárůstu frekvence podáváme profylakticky např. antidepresiva a doplňujeme nefarmakologickými metodami.

Keywords: bolest hlavy, migréna, akutní léčba, profylaxe, analgetika, triptany, tenzní bolest hlavy

Published: March 27, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Niedermayerová I. Farmakologická léčba bolestí hlavy. Med. praxi. 2008;5(1):41-44.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Diener H. Established treatment strategies for varying clinical situations. The 13th Congress of the IHS 2007, Stockholm, Sweden.
    2. Dočekal P, Keller O, Marková J, Opavský J. Bolesti hlavy. In Rokyta R, Kršiak M, Kozák J (Eds). Bolest. Praha: Tigis 2006: 461-476.
    3. Doležal T, Slíva J. Nimesulidum. Remedia 2004; 14: 2-10.
    4. Evers S, Áfra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. European Journal of Neurology 2006; 13: 560-572. Go to original source... Go to PubMed...
    5. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a metaanalysis of 53 trials. Lancet. 2001; 358: 1668-75. Go to original source... Go to PubMed...
    6. Mastík J. Specifická léčba migrény. Interní Med. 2007; 4: 188-191.
    7. Niedermayerová I, Mastík J. Lisinopril je účinný v profylaxi migrény. Practicus. 2007; 5-6: 200-203.
    8. Opavský J, Doležil D, Mastík J, Marková J, Grünermelová M, Niedermayerová I, Rejda J, Dočekal P, Opavská H. Comparison between migraine treatment by headache specialists and primary care physicians in the Czech republic. Cephalalgia. 2007; 27, 652-653.
    9. Peatfield P, Dodick DW. Headaches. Fine Print, Oxford, 2002: 176-201.
    10. Rainsford KD. Current status of the therapeutic uses and actions of the preferential cyklo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology. 2006; 14: 120-137. Go to original source... Go to PubMed...
    11. Relja G, Granato A, Antonello RD, Zorzon M. Headache Induced by Chronic Substance Use: Analysis of Medication Overused and Minimum Dose Required to Induce Headache. Headache 2004; 44: 148-153. Go to original source... Go to PubMed...
    12. Rasmussen, BK, Jensen R, Schroll M, Olesen J. Epidemiology of headaches in a general population. J Clin Epidemiol. 1991; 44: 1147-1157. Go to original source... Go to PubMed...
    13. Slíva J, Doležal T, Kršiak M. Přehled analgetik. Praha: Tigis, 2004.
    14. Stratified Care vs Step Care Strategies for migraine. The Disability in Strategies of care (DISC) Study: Randomised Trial. JAMA. 2000; 284; 2599-2605. Go to original source... Go to PubMed...
    15. The International Classification of Headache Disorders. 2nd Edition, Cephalgia 2003; 24 (Suppl 1/24): 1-160.
    16. Waberžinek G. Bolesti hlavy. Praha: Triton, 2000: 66-116.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.